PURAPHARM CORPORATION LIMITED financial statements, including revenue, expenses, and profit
The total revenue of 1498 for the last semiannual is 174.46 M HKD, and it's 15.97% lower compared to the previous semiannual. The net income of H2 24 is -16.75 M HKD.